CapEx at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s capex?
- Collegium Pharmaceutical, Inc. (COLL) reported capex of $270K in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s capex changed year-over-year?
- Collegium Pharmaceutical, Inc.'s capex decreased by 66.2% year-over-year, from $798K to $270K.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s capex?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s capex has grown at a -2.7% compound annual growth rate (CAGR), from $1.94M to $1.74M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.